Terms: = Germ cell tumor AND RANBP2, NUP358, 5903, ENSG00000153201, P49792, TRP1, TRP2 AND Clinical Outcome
2 results:
1. Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients.
Fässler M; Diem S; Mangana J; Hasan Ali O; Berner F; Bomze D; Ring S; Niederer R; Del Carmen Gil Cruz C; Pérez Shibayama CI; Krolik M; Siano M; Joerger M; Recher M; Risch L; Güsewell S; Risch M; Speiser DE; Ludewig B; Levesque MP; Dummer R; Flatz L
J Immunother Cancer; 2019 Feb; 7(1):50. PubMed ID: 30786924
[TBL] [Abstract] [Full Text] [Related]
2. Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes.
Riker AI; Kammula US; Panelli MC; Wang E; Ohnmacht GA; Steinberg SM; Rosenberg SA; Marincola FM
Int J Cancer; 2000 Jun; 86(6):818-26. PubMed ID: 10842196
[TBL] [Abstract] [Full Text] [Related]
